Literature DB >> 15710986

Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid.

K Birkenkamp-Demtroder1, S H Olesen, F B Sørensen, S Laurberg, P Laiho, L A Aaltonen, T F Orntoft.   

Abstract

BACKGROUND AND AIMS: There are epidemiological, morphological, and molecular differences between normal mucosa as well as between adenocarcinomas of the right and left side of the large bowel. The aim of this study was to investigate differences in gene expression.
METHODS: Oligonucleotide microarrays (GeneChip) were used to compare gene expression in 45 single samples from normal mucosa and sporadic colorectal carcinomas (Dukes' B and C) of the caecum compared with the sigmoid and rectosigmoid. Findings were validated by real time polymerase chain reaction.
RESULTS: Fifty eight genes were found to be differentially expressed between the normal mucosa of the caecum and the sigmoid and rectosigmoid (p<0.01), including pS2, S100P, and a sialyltransferase, all being expressed at higher levels in the caecum. A total of 118 and 186 genes were differentially expressed between normal and right or left sided tumours of the colon, showing more pronounced differences in Dukes' C than B tumours. Thirty genes differentially expressed in tumour tissue were common to adenocarcinomas of both sides, including known tumour markers such as the matrix metalloproteinases. Keratins 8, 19, and 20 as well as carbonic anhydrases (II, IV, VII) showed side specific expression and were downregulated in left sided tumours whereas teratocarcinoma growth factor and cyclooxygenase 2 (COX-2) were upregulated in left sided adenocarcinomas. Immunohistochemical analysis confirmed differences in side specific expression for cytokeratin 20 and COX-2.
CONCLUSIONS: Differences in gene expression between normal mucosa as well as between adenocarcinomas of the caecum and sigmoid or rectosigmoid exist and should be taken into account when examining new targeted therapeutic regimens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710986      PMCID: PMC1774427          DOI: 10.1136/gut.2003.036848

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays.

Authors:  D A Notterman; U Alon; A J Sierk; A J Levine
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

2.  Mechanisms of oncogenesis in colon versus rectal cancer.

Authors:  E Kapiteijn; G J Liefers; L C Los; E K Kranenbarg; J Hermans; R A Tollenaar; Y Moriya; C J van de Velde; J H van Krieken
Journal:  J Pathol       Date:  2001-09       Impact factor: 7.996

3.  Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166.

Authors:  Kouji Oba; Hiroyuki Konno; Tatsuo Tanaka; Megumi Baba; Kinji Kamiya; Manabu Ohta; Takeshi Kaneko; Tsuyoshi Shouji; Akira Igarashi; Satoshi Nakamura
Journal:  Cancer Lett       Date:  2002-01-10       Impact factor: 8.679

4.  Zymographic analysis of circulating and tissue forms of colon carcinoma gelatinase A (MMP-2) and B (MMP-9) separated by mono- and two-dimensional electrophoresis.

Authors:  I Pucci-Minafra; S Minafra; G La Rocca; M Barranca; S Fontana; G Alaimo; Y Okada
Journal:  Matrix Biol       Date:  2001-11       Impact factor: 11.583

5.  Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats.

Authors:  T Aparicio; S Kermorgant; V Dessirier; M J Lewin; T Lehy
Journal:  Carcinogenesis       Date:  1999-08       Impact factor: 4.944

6.  Different expression of some molecular markers in sporadic cancer of the left and right colon.

Authors:  P Fric; V Sovová; E Sloncová; Z Lojda; A Jirásek; J Cermák
Journal:  Eur J Cancer Prev       Date:  2000-08       Impact factor: 2.497

7.  Clinicopathological differences between colonic and rectal carcinomas: are they based on the same mechanism of carcinogenesis?

Authors:  K Konishi; T Fujii; N Boku; S Kato; I Koba; A Ohtsu; H Tajiri; A Ochiai; S Yoshida
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

8.  Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways.

Authors:  Janiel M Shields; Kelley Rogers-Graham; Channing J Der
Journal:  J Biol Chem       Date:  2001-12-28       Impact factor: 5.157

9.  Gene expression in colorectal cancer.

Authors:  Karin Birkenkamp-Demtroder; Lise Lotte Christensen; Sanne Harder Olesen; Casper M Frederiksen; Päivi Laiho; Lauri A Aaltonen; Søren Laurberg; Flemming B Sørensen; Rikke Hagemann; Torben F ØRntoft
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

10.  Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins.

Authors:  J Wehkamp; B Schwind; K R Herrlinger; S Baxmann; K Schmidt; M Duchrow; C Wohlschläger; A C Feller; E F Stange; K Fellermann
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

View more
  103 in total

Review 1.  Adjuvant chemotherapy for rectal cancer: Is it needed?

Authors:  Kristijonas Milinis; Michael Thornton; Amir Montazeri; Paul S Rooney
Journal:  World J Clin Oncol       Date:  2015-12-10

2.  The Relationship between the Methylated Septin-9 DNA Blood Test and Stool Occult Blood Test for Diagnosing Colorectal Cancer in Taiwanese People.

Authors:  Chung-Hung Chen; Sheng-Lei Yan; Tsung-Hsun Yang; Shih-Feng Chen; Yung-Hsiang Yeh; Jing-Jim Ou; Chien-Hua Lin; Yueh-Tsung Lee; Chien-Hua Chen
Journal:  J Clin Lab Anal       Date:  2016-07-08       Impact factor: 2.352

3.  The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers.

Authors:  Rob Glynne-Jones; Maher Hadaki; Mark Harrison
Journal:  J Gastrointest Oncol       Date:  2013-09

4.  Characterization of a lipid hydroperoxide-derived RNA adduct in rat intestinal epithelial cells.

Authors:  Peijuan Zhu; Seon Hwa Lee; Suzanne Wehrli; Ian A Blair
Journal:  Chem Res Toxicol       Date:  2006-06       Impact factor: 3.739

5.  Clinical and prognostic differences between surgically resected right-sided and left-sided colorectal cancer.

Authors:  Koji Fukata; Norihiro Yuasa; Eiji Takeuchi; Hideo Miyake; Hidemasa Nagai; Yuichiro Yoshioka; Kanji Miyata
Journal:  Surg Today       Date:  2019-10-14       Impact factor: 2.549

6.  A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation.

Authors:  A E Moore; L E Young; D A Dixon
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

7.  Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study.

Authors:  Erik Rahimi; Sachin Batra; Nirav Thosani; Harminder Singh; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2016-04-23       Impact factor: 3.199

8.  Gene expression in colon cancer: A focus on tumor site and molecular phenotype.

Authors:  Martha L Slattery; Daniel F Pellatt; Lila E Mullany; Roger K Wolff; Jennifer S Herrick
Journal:  Genes Chromosomes Cancer       Date:  2015-07-14       Impact factor: 5.006

Review 9.  The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis.

Authors:  Masashi Yahagi; Koji Okabayashi; Hirotoshi Hasegawa; Masashi Tsuruta; Yuko Kitagawa
Journal:  J Gastrointest Surg       Date:  2015-11-16       Impact factor: 3.452

10.  HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling.

Authors:  Young-Rang Kim; Kyung-Jin Oh; Ra-Young Park; Nguyen Thi Xuan; Taek-Won Kang; Dong-Deuk Kwon; Chan Choi; Min Soo Kim; Kwang Il Nam; Kyu Youn Ahn; Chaeyong Jung
Journal:  Mol Cancer       Date:  2010-05-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.